Ipsen Completes Memo Therapeutics Acquisition
PARIS, France, July 22, 2026 Ipsen has completed its acquisition of Memo Therapeutics AG, strengthening its Rare Disease pipeline...
Clinical Laboratory
Advertisement
Atossa Unveils (Z)-Endoxifen Data for Rare Endocrine Disease
SEATTLE, July 21, 2026 Atossa Therapeutics has presented new preclinical mechanism-driven data supporting the therapeutic potential of (Z)-Endoxifen for...
Seegene USA Wins FDA EUA for Multiplex PCR Assay
SEOUL, South Korea & IRVINE, Calif., July 21, 2026 Seegene USA has received Emergency Use Authorization (EUA) from the...
Eurofins Viracor Expands Cytokine Testing Portfolio
LENEXA, Kan., July 16, 2026 Eurofins Viracor has expanded its immunology testing portfolio with the launch of three new...
AmeriWater Acquires Med Water to Expand Clinical Solutions
DAYTON, Ohio, July 17, 2026 AmeriWater, a leading provider of water purification systems for critical healthcare applications, has announced...
Advertisements
Moderna and Oxford Launch Phase 1/2 Trial of mRNA Cancer Vaccine for Lynch Syndrome
OXFORD, UK AND CAMBRIDGE, Massachusetts – June 8, 2026 Moderna and the University of Oxford have received authorization from...
Johnson & Johnson Acquires Firefly Bio to Boost Oncology
NEW BRUNSWICK, New Jersey, USA – June 8, 2026 Johnson & Johnson has announced a definitive agreement to acquire...
Waters Secures FDA Clearance for BD BACTEC FXI System
MILFORD, Massachusetts, USA – June 3, 2026 Waters Corporation has announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
Advertisement
